View Author
patient achalasia esophageal cancer study treatment barrett esophagus dilatation follow-up achalasia patients esophageal cancer symptom surveillance leeuwenburgh recurrence carcinoma disease ivonne 24-02-12 biopsy esophageal carcinoma endoscopy development chapter sample pressure stent hiatal hernia balloon therapy diagnosis dilation esophagiti stasis incidence range cohort food stasis result dysplasia inflammation factor cell carcinoma gastroenterol p 53 overexpression grade protocol month outcome myotomy analysis number prevalence reflux hernia hiatal predictor gastroenterology oesophageal adenocarcinoma barium esophagram presence metaplasia barium manometry population symptom recurrence endoscopic expression ppi therapy risk factors interval disorder hazard biopsy sampling hazard ratio table thyroid disease figure
8 Most Recent Publications
|
Efficacy and safety of a partially covered stent in malignant gastric outlet obstruction: A prospective Western series
(Article)
Didden, P. Spaander, M.C.W. Ridder, R. de Berk, L. Tilburg, A.J.P. van Leeuwenburgh, I. Kuipers, E.J. Bruno, M.J. |
2013-04-01
|
|
Achalasia, Studies on Long-Term Outcome
(Doctoral Thesis)
Leeuwenburgh, I. |
2012-04-18
|
|
Practice patterns for achalasia - Room for improvement?
(Letter To Editor)
Leeuwenburgh, I. Alderliesten, J. Vries, A.C. de Kuipers, E.J. |
2011-07-01
|
|
Predictors for outcome of failure of balloon dilatation in patients with achalasia
(Article)
Alderliesten, J. Conchillo, J.M. Leeuwenburgh, I. Steyerberg, E.W. Kuipers, E.J. |
2011-01-01
|
|
Long-Term Esophageal Cancer Risk in Patients With Primary Achalasia: A Prospective Study
(Article)
Leeuwenburgh, I. Scholten, P. Alderliesten, J. Tilanus, H.W. Looman, C.W.N. Steijerberg, E.W. Kuipers, E.J. |
2010-10-01
|
|
Expression of p53 as predictor for the development of esophageal cancer in achalasia patients
(Article)
Leeuwenburgh, I. Gerrits, M.M. Capello, A. Bogert, B. van den Dekken, H. van Steyerberg, E.W. Siersema, P.D. Kuipers, E.J. |
2010-08-01
|
|
Proton pump inhibitor therapy in gastro-oesophageal reflux disease decreases the oesophageal immune response but does not reduce the formation of DNA adducts
(Article)
Jonge, P.J.F. de Siersema, P.D. Breda, S.G.J. van Zoest, K.P.M. van Bac, D.J. Leeuwenburgh, I. Ouwendijk, R.J.T. Dekken, H. van Kusters, J.G. Kuipers, E.J. |
2008-07-01
|
|
Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy
(Article)
Leeuwenburgh, I. Lugtenburg, P.J. Buuren, H.R. van Zondervan, P.E. Man, R.A. de |
2008-02-01
|
